Singota Solutions Capacity Update July 2024

On July 22nd, 2024, Singota Solutions (Bloomington, Indiana CDMO) proudly served as a featured presenter at their key industry event "OPCU #3," showcasing our expertise in critical areas of pharmaceutical manufacturing and logistics. As a leader in small batch aseptic filler technologies and aseptic manufacturing solutions (aseptic filling), Singota shared…

Systematic Approach To Early Phase Sterile Drug Product Technology Transfer

Initial scale-up of a sterile drug product manufacturing process (early phase) can present significant challenges and risks to new drug development timelines, budgets, product quality, and patient safety if not properly managed. At Singota Solutions (Bloomington, Indiana CDMO), our expertise in injectable formulation development, combined with our advanced aseptic manufacturing…

Captisol®: What gives EuropeanPharmacopeia?!

Analytical Method Challenges for EP Monograph, Captisol ® At the 2023 American Drug Delivery and Formulation Summit, Ryan Memmer from Singota Solutions (leading CDMO in Bloomington, Indiana), captivated the audience with his insightful presentation on "Analytical Method Challenges for EP Monograph," titled "Captisol®: What gives European Pharmacopeia?!" Memmer's expertise in…

Specializing In Small And Early-Stage Injectables, Not Just Small Batches

Source: Singota Solutions Navigating the complex landscape of pharmaceutical development (Injectables), particularly for small and early-stage companies, demands careful consideration of manufacturing partnerships. While large CDMOs may seem like obvious choices, their focus on high-volume production often leaves smaller projects sidelined. This shift is notable in the context of the industry's…

Analysis Paralysis: Navigating Early-Phase Analytical Validation

Significant confusion persists across the pharmaceutical/biopharmaceutical industry relevant to early-phase analytical development and analytical validation. While several guidance documents serve as a de facto standard, distinguishing method validation requirements from suggestions, when and how to apply those guidelines often is not a straightforward task.It is critical to establish a product/project’s…